Advertisement
Skip to Content

Polydex Pharmaceuticals Ltd POLXF Stock Quote

| Rating as of

PINX: POLXF

Last close prices updated as of Jan 17, 2023, 2:49 PM EST | USD
  • Last Close 0.551
  • Sector Healthcare
  • Industry Biotechnology
  • Investment Style Small Value
  • Day Range 0.55  –  0.55
  • Year Range 0.55  –  48.44
  • Market Cap 1.8913 Mil
  • Volume / Avg 370.0 /  3,849.7
  • Price / Sales 0.00
  • Price / Book 0.00
  • Forward Div Yield 2.07%
  • Trailing Div Yield

Morningstar‘s Stock Analysis POLXF

Valuation
Currency in
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price

INVESTOR

5-Star Price

INVESTOR

Economic Moat

INVESTOR

About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Unlock Our Full Analysis With Morningstar Investor

Key Statistics POLXF

Company Profile POLXF

Business Description

Polydex Pharmaceuticals Ltd is engaged in the development, manufacturing, and marketing of biotechnology-based products for the human pharmaceutical market. In addition, it also engaged in the manufacture and sale of veterinary pharmaceutical products and specialty chemicals. It focuses on the manufacture and sale of Dextran and derivative products, including Iron Dextran and Dextran Sulphate, and other specialty chemicals. Geographically sale of the products can be seen amplifying in the region of Europe, United States, Canada, and other countries of which the United States region accounts for the larger share of revenue.

Contact
421 Comstock Road
Toronto, ON, M1L 2H5, CAN
Industry Biotechnology
Employees 21

FAQs for Polydex Pharmaceuticals Ltd Stock

Yes. POLXF has a forward dividend yield of 2.07%. See POLXF’s full dividends and stock split history on the Dividend tab.
Dividend yield allows investors, particularly those interested in dividend-paying stocks, to compare the relationship between a stock’s price and how it rewards stockholders through dividends. The formula for calculating dividend yield is to divide the annual dividend paid per share by the stock price.

Learn more about dividend yield.

POLXF’s market cap is 1.89 Mil.
Market capitalization is calculated by taking a company’s share price and multiplying it by the total number of shares. It’s often used to measure a company’s size. In the Morningstar Style Box, large-cap names account for the largest 70% of U.S. stocks, mid-cap names account for the largest 70–90%, and small-cap names are the remaining 10% of companies.

Learn more about market capitalization.

POLXF’s beta can be found in Trading Information at the top of this page.
A stock’s beta measures how closely tied its price movements have been to the performance of the overall market.

Compare POLXF’s historical performance against its industry peers and the overall market.